Dr. David Peereboom, MD
Claim this profileCleveland Clinic
Expert in Glioblastoma
Studies Brain Tumor
19 reported clinical trials
31 drugs studied
Area of expertise
1Glioblastoma
Global LeaderMGMT positive
Stage IV
IDH negative
2Brain Tumor
IDH positive
MGMT positive
MGMT negative
Affiliated Hospitals
Clinical Trials David Peereboom, MD is currently running
Methimazole
for Brain Tumor
The purpose of this study is to test the effectiveness, safety, and tolerability of a drug called Methimazole. The investigational drug, Methimazole is not FDA approved for brain tumors, but it is used to treat thyroid illnesses. Different doses of Methimazole will be given to several study participants with glioblastoma. The first several study participants will receive the lowest dose. If the drug does not cause serious side effects, it will be given to other study participants at a higher dose. The doses will continue to increase for every group of study participants until the side effects occur that require the dose to be lowered. The procedures in this study are research blood draws, physical exams, collection of medical history, MRI scans, and study drug administration.
Recruiting1 award Phase 2
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
More about David Peereboom, MD
Clinical Trial Related5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments David Peereboom, MD has experience with
- Temozolomide
- Radiation
- Regorafenib
- Bevacizumab
- Lomustine
- Eflornithine
Breakdown of trials David Peereboom, MD has run
Glioblastoma
Brain Tumor
Benign Glioma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Peereboom, MD specialize in?
David Peereboom, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MGMT positive patients, or patients who are Stage IV.
Is David Peereboom, MD currently recruiting for clinical trials?
Yes, David Peereboom, MD is currently recruiting for 6 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that David Peereboom, MD has studied deeply?
Yes, David Peereboom, MD has studied treatments such as Temozolomide, Radiation, Regorafenib.
What is the best way to schedule an appointment with David Peereboom, MD?
Apply for one of the trials that David Peereboom, MD is conducting.
What is the office address of David Peereboom, MD?
The office of David Peereboom, MD is located at: Cleveland Clinic, Cleveland, Ohio 44106 United States. This is the address for their practice at the Cleveland Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.